ALPS ETF TR - MED BREAKTHGH (SBIO)

Historical Holders from Q4 2014 to Q3 2025

Symbol: SBIO
Type / Class: Equity / MED BREAKTHGH
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 2,463,410
Holdings value: $74,362,888
% of all portfolios: 0%
Number of holders: 37
Number of buys: 13
Number of sells: 16
Average buys %: +0%
Average sells %: -0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

As of 30 Sep 2025 ALPS ETF TR - MED BREAKTHGH (SBIO) has 37 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 2,463,410 shares of the company stock as of 30 Sep 2025.

Institutional Holders of ALPS ETF TR - MED BREAKTHGH (SBIO) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	2,463,410	$74,362,888	-$11,326,386			$38.86	37
2025 Q2	2,764,856	$74,301,622	-$3,456,424	$0	$0	$30.07	35
2025 Q1	2,884,515	$72,984,477	+$30,442,870	$5,704	$34,222	$28.52	33
2024 Q4	1,485,532	$49,104,003	+$1,992,411	$6,606	$33,030	$33.03	35
2024 Q3	1,434,930	$52,950,164	-$250,445		$0	$37.33	36
2024 Q2	1,418,814	$47,816,949	-$668,734	$0	$13,433	$33.58	37
2024 Q1	1,438,262	$51,309,167	+$4,226,181	$71,500	$475,475	$35.75	37
2023 Q4	1,209,866	$39,891,941	-$269,702	$131,765	$250,345	$32.94	34
2023 Q3	1,223,130	$33,294,401	-$1,547,873	$108,884	$321,197	$27.22	34
2023 Q2	1,406,121	$44,270,591	-$128,377	$37,860	$873,935	$31.55	40
2023 Q1	1,408,049	$38,276,866	-$1,351,779	$54,369	$201,166	$27.18	36
2022 Q4	1,459,524	$44,254,889	+$14,757,426	$72,912	$258,230	$30.38	45
2022 Q3	963,215	$29,018,762	-$2,264,408		$280,000	$30.11	40
2022 Q2	1,054,296	$29,211,470	-$6,501,075		$498,000	$27.69	47
2022 Q1	1,289,099	$43,376,551	-$10,685,060		$1,197,000	$33.64	53
2021 Q4	1,582,332	$66,017,782	+$3,627,287	$0	$1,538,000	$42.24	61
2021 Q3	1,553,700	$69,122,390	-$1,467,742	$218,000	$1,388,000	$45.51	60
2021 Q2	1,520,791	$73,292,731	-$378,747	$519,000	$1,571,000	$48.91	63
2021 Q1	1,590,289	$79,026,850	+$4,937,133	$573,000	$2,609,000	$50.26	70
2020 Q4	1,409,308	$72,239,924	+$340,896	$323,000	$1,967,000	$51.22	63
2020 Q3	1,403,873	$57,742,238	-$1,816,949	$0	$1,363,000	$41.13	49
2020 Q2	1,433,577	$59,949,601	+$1,878,042	$213,000	$1,791,000	$41.83	49
2020 Q1	1,424,074	$45,145,127	+$4,232,480	$258,000	$832,000	$31.70	43
2019 Q4	1,306,669	$55,223,451	-$3,001,715		$3,767,000	$42.28	50
2019 Q3	1,379,765	$44,006,929	+$756,135	$6,000	$2,338,000	$31.56	46
2019 Q2	1,346,589	$48,639,787	+$2,079,336	$215,000	$2,395,000	$36.12	44
2019 Q1	1,297,189	$46,924,684	-$8,669,508	$785,000	$1,914,000	$36.18	45
2018 Q4	1,596,432	$44,995,968	-$17,914,133	$0	$839,000	$28.14	46
2018 Q3	2,142,111	$84,334,055	+$15,182,705	$884,000	$901,000	$39.37	53
2018 Q2	1,755,390	$65,400,864	+$16,203,724	$373,000	$917,000	$37.27	44
2018 Q1	1,316,809	$45,065,270	+$20,163,509	$644,000	$1,356,000	$34.22	41
2017 Q4	727,296	$23,856,507	+$3,261,648	$603,000	$597,000	$32.78	34
2017 Q3	616,649	$19,222,356	+$712,214	$530,000	$703,000	$31.17	27
2017 Q2	563,199	$15,684,466	-$3,932,195	$554,000	$379,000	$27.85	21
2017 Q1	713,494	$18,359,904	+$846,783	$286,000	$592,000	$25.76	24
2016 Q4	701,962	$16,118,143	-$1,261,692	$0	$316,000	$22.92	26
2016 Q3	658,984	$17,190,000	+$4,184,839	$475,000	$462,000	$26.10	27
2016 Q2	579,496	$13,155,068	-$999,647	$663,000	$849,000	$22.63	27
2016 Q1	613,629	$13,539,875	-$9,429,822	$0		$21.90	21
2015 Q4	995,377	$31,017,512	+$12,893,085	$747,000		$31.73	30
2015 Q3	573,923	$16,068,325	+$5,728,645	$589,000		$27.88	28
2015 Q2	361,555	$12,842,975	+$8,990,787			$35.52	18
2015 Q1	109,334	$3,273,487	+$1,860,488			$29.91	13
2014 Q4	56,793	$1,411,000	+$1,411,000			$24.92	2